Provocative discography is the gold standard for diagnosing discogenic pain – it allows precise identification of which specific intervertebral disc is the source of chronic low back pain. At our Centre, we combine it with therapeutic methylene blue injection, achieving both a diagnostic and therapeutic effect in a single procedure.

What is Discogenic Pain and Why is it Difficult to Diagnose?

Degenerative disc disease (DDD) accounts for 28–43% of chronic low back pain cases. Discogenic pain arises when degenerating discs develop so-called annular tears in the fibrous ring, into which new terminal branches of pain nerve fibres (sinuvertebral nerve branches) grow. Additionally, the disc releases inflammatory mediators (TNF-α, IL-1β, NO) that sensitise these nerve endings.

The problem: MRI often shows degeneration at multiple disc levels, but only some of them are the actual pain source. MRI cannot answer the question: WHICH SPECIFIC disc is causing pain. Provocative discography is the only method that provides this answer.

What Does Provocative Discography Involve?

Under fluoroscopic X-ray guidance, in sterile conditions, fine needles are introduced into each disc being investigated (per ISIS guidelines – minimum 2 adjacent discs, including at least 1 as a control).

  • A small amount of X-ray contrast is injected into each disc under controlled pressure.
  • The patient is awake during the examination (without general sedation) and describes their sensations: whether injection into the contrast reproduces their familiar, characteristic pain or not.
  • Positive test: injection into a given disc reproduces the patient’s familiar pain in its typical location and intensity – this disc is the pain source.
  • Negative test (control disc): injection into another disc does not cause pain or causes pain of a different character.
  • Simultaneous morphological assessment under fluoroscopy: visible annular tears, contrast leakage into the epidural space.

Why Do We Add Methylene Blue?

Methylene blue (MB) is a low molecular weight dye with documented neuromodulatory and anti-inflammatory properties. After confirming that a given disc is the pain source (via the provocative test), we inject 1 ml of MB (10 mg) into that disc – using the same needle used for discography.

Mechanism of action of methylene blue in discogenic pain:

  • Neurotropic action – MB blocks the pain nerve fibre endings growing into the fibrous ring
  • Anti-inflammatory action – inhibition of nitric oxide synthase (NOS), reduction of pro-inflammatory mediators
  • Antioxidant action – scavenging of free radicals in the degenerating disc
  • Possible modulation of inflammatory granulation tissue proliferation in annular tears

The first randomised controlled trials (Peng 2010, n=72, 24-month follow-up) showed NRS pain reduction of 52.5 points in the MB group vs 0.7 in the placebo group, ODI reduction of 35.6 vs 1.7, satisfaction 91.6% vs 14.3%. Subsequent studies (Kim 2012, Zhang 2016) confirmed short- and medium-term efficacy, although one European study (Kallewaard 2019) did not confirm the effect – the method remains the subject of ongoing research.

Indications

  • Chronic low back pain (>6 months) without a dominant radicular component
  • Ambiguous MRI – several degenerating discs, unclear which is the pain source
  • Failure of conservative treatment (NSAIDs, physiotherapy, blocks)
  • Patient considering spinal surgery – discography qualifies the patient for surgery or allows deferral
  • Preserved spinal stability (no spondylolisthesis, advanced deformity)
  • No significant radicular pathology (sciatica) as the primary problem

Procedure Sequence

  • Detailed pre-procedure consultation – MRI analysis, discussion of the procedure’s purpose (diagnosis + treatment).
  • Patient in the prone or lateral position, comfortable but conscious. Light local skin anaesthesia, WITHOUT sedation (the patient must be in contact and able to describe sensations).
  • Under fluoroscopic X-ray guidance, needles are introduced into at least 2 adjacent discs.
  • Provocative test – injection of contrast into each disc, documentation of the patient’s response (concordant/discordant pain), disc morphology (annular tears, contrast leakage).
  • After identifying the painful disc – injection of 1 ml methylene blue (10 mg) through the same needle.
  • Post-procedure observation for 1–2 hours; same-day discharge.
  • Duration of the entire procedure: 30–60 minutes.

Preparation

  • Current lumbar spine MRI (no older than 6 months)
  • Antibiotic prophylaxis – a single intravenous antibiotic dose 30 minutes before the procedure (to prevent discitis)
  • Discontinuation of anticoagulants per protocol
  • Fasting for 6 hours before the procedure
  • Informed consent – the patient must understand the nature of the provocative test (brief deliberate pain reproduction is intentional and diagnostic)
  • Return transport

Therapeutic Effects

  • First relief: 3–14 days after the procedure
  • Full effect: 1–3 months
  • Duration of effect (based on available studies): 6–24 months
  • In the best responders (Peng 2010 studies): >50% pain reduction sustained for 24 months in 91.6% of patients
  • In some patients (Kim 2012 studies): effect significantly shorter, up to 6 months
  • Regardless of the MB effect – discography itself provides INVALUABLE diagnostic information about which disc is painful, enabling precise planning of further treatment (e.g. stabilisation, ozone nucleolysis, intradiscal PRP Angel)

Possible Side Effects

  • Transient low back pain after the procedure (up to 1 week) – intensified for the first 2–3 days
  • Haematoma/tenderness at the puncture site
  • Slight greenish-blue urine discolouration (MB elimination) – a physiological phenomenon resolving after 24 hours
  • Very rarely (<0.1%): discitis (prevented by antibiotic prophylaxis), allergic reaction to contrast/MB, bleeding
  • In patients with G6PD deficiency: risk of haemolysis – MB is absolutely contraindicated in these patients

FAQ

Is discography painful?

The provocative test INTENTIONALLY reproduces the patient’s familiar pain (briefly – for a few seconds) to confirm that the disc in question is its source. This is a critical diagnostic component. The procedure itself is performed under local anaesthesia, so discomfort is minimal. Moderate low back pain may persist for 2–7 days post-procedure.

Can I undergo discography without methylene blue injection?

Yes – discography alone as a diagnostic examination (without the therapeutic MB effect) is possible. At our Centre we routinely combine both procedures, but at the patient’s request or if there are contraindications to MB (G6PD deficiency), we perform discography alone.

Can discography with MB replace spinal surgery?

In some well-selected patients – yes. In others it is an excellent diagnostic tool enabling the surgeon to precisely identify which level to operate on. The decision on surgery always remains individual.